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Contraception is a lifesaving and essential 
component of healthcare. Since COVID-19 
disrupted routine health service delivery, 
increased use of digital health (or mHealth) 
has been required to reduce risks to patients 
and healthcare workers1 2 A recent systematic 
review was, however, unable to draw concrete 
conclusions on the overall effectiveness of 
mHealth interventions to increase contracep-
tion use in low- income and middle- income 
countries.3 A meta- analysis was not possible 
due to differences between study popula-
tions, interventions and outcomes. In the 
meantime, another trial reported no measur-
able effect of an mHealth intervention for 
female sex workers on unintended pregnancy 
in Kenya, adding to the mixed evidence.4 A 
better evidence base for digital health inter-
ventions to increase contraception use is 
required, but how can this be achieved?
First, a common set of study outcome 
measures for interventions for contraception 
is required. To date, a variety of approaches 
to measuring contraception use have been 
used, to assess current use or adherence over 
time. While objective measures such as using 
biological markers or electronic medication 
monitors are considered less prone to bias, 
their use is challenging.5 Thus subjective 
measures enquiring about self- reported use 
remain de rigueur for most trials, accepting 
their known biases. An expert working group 
could be convened with the aim of harmon-
ising contraceptive trial outcomes in order 
to reduce heterogeneity between studies and 
allow future meta- analyses.
Second, a deeper examination of the 
intervention mode of delivery and resource 
requirements is required. Distinctions 
between unidirectional and interactive inter-
ventions are important but the intensity and 
mode of interaction needs further evaluation. 
The ideal digital health intervention would be 
fully automated, scalable, safe and effective. It 
remains to be seen whether this is possible for 
contraception where there are a wide range 
of methods, cultural beliefs and nuanced side 
effects. Further understanding of the degree 
of personal interaction required and overall 
resource implications are important consid-
erations for service providers when consid-
ering replicability and scale.
Third, now is the time to conduct larger 
studies that have shown to be effective, or 
promising but underpowered, and prioritised 
over trials of new interventions. Trials could 
be undertaken in different settings, but use 
the same outcome measures, maintaining the 
core components of the original intervention, 
subject to cultural or linguistic adaptions that 
might be required. This should result in an 
increased evidence base for service providers 
wanting to adopt best practices in digital 
health in their contraception programmes.
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